PROGEN

PROGEN was founded in 1983 by four scientists from Heidelberg, Germany, who joined forces to manufacture and supply high-quality antibodies for biomedical research.

We help scientists worldwide drive biopharmaceutical and diagnostic progress to provide high-quality and reliable treatments for patients. Our mission is to provide high-quality products that help advance new therapies and develop existing research processes safely, quickly, and affordably for the life science community.

The PROGEN team consists of bioscientists and adeno-associated virus (AAV) experts who collaborate with specialists around the world.

We are more than just a manufacturer of antibodies, AAV gene therapy tools, density gradient media, and phage display technologies: We strive to understand the needs of scientists to develop solutions to jointly address the challenges in academic research, biotechnology, and pharma.